Comments on the Background Document on Propylparaben and Butylparaben in Skin-Applied Leave-On Products Share page: Download Document Issues: OTC Medicines Sunscreen Related Posts Press Releases and Statements CHPA Comments on News of Dismissals & Layoffs at FDA Feb 18, 2025 Press Releases and Statements CHPA Responds to Senate Confirming RFK Jr. to Lead HHS Feb 12, 2025 Press Releases and Statements CHPA Highlights Critical Importance of Consumer Healthcare, Warns of Unintended Consequences from Tariffs Feb 3, 2025